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Abstract
Background: The present study investigated whether changes in gene expression in the right ventricle following pulmonary
hypertension can be attributed to hypoxia or pressure loading.
Methodology/Principal Findings: To distinguish hypoxia from pressure-induced alterations, a group of rats underwent
banding of the pulmonary trunk (PTB), sham operation, or the rats were exposed to normoxia or chronic, hypobaric hypoxia.
Pressure measurements were performed and the right ventricle was analyzed by Affymetrix GeneChip, and selected genes
were confirmed by quantitative PCR and immunoblotting. Right ventricular systolic blood pressure and right ventricle to
body weight ratio were elevated in the PTB and the hypoxic rats. Expression of the same 172 genes was altered in the
chronic hypoxic and PTB rats. Thus, gene expression of enzymes participating in fatty acid oxidation and the glycerol
channel were downregulated. mRNA expression of aquaporin 7 was downregulated, but this was not the case for the
protein expression. In contrast, monoamine oxidase A and tissue transglutaminase were upregulated both at gene and
protein levels. 11 genes (e.g. insulin-like growth factor binding protein) were upregulated in the PTB experiment and
downregulated in the hypoxic experiment, and 3 genes (e.g. c-kit tyrosine kinase) were downregulated in the PTB and
upregulated in the hypoxic experiment.
Conclusion/Significance: Pressure load of the right ventricle induces a marked shift in the gene expression, which in case of
the metabolic genes appears compensated at the protein level, while both expression of genes and proteins of importance
for myocardial function and remodelling are altered by the increased pressure load of the right ventricle. These findings
imply that treatment of pulmonary hypertension should also aim at reducing right ventricular pressure.
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Introduction
Pulmonary arterial hypertension is a heterogeneous group of
disorders characterized by increased pulmonary artery pressure
and resistance as a result of pulmonary vascular remodeling, active
vasoconstriction, and in-situ thrombosis. The increased pressure
load results in right ventricular hypertrophy representing an initial
stage which can progress to failure and death [1]. The current
treatments with prostaglandin (PGI2) analogues (e.g. epoproste-
nol), endothelin receptor antagonists (e.g. bosentan), and phos-
phodiesterase 5 inhibitors (e.g. sildenafil) have markedly improved
the prognosis of the disease [2]. Direct inotropic effects of
epoprostenol on the right ventricle was described [3,4] and that
bosentan reduces cardiac fibrosis and hypertrophy [5]. However,
these treatments are mainly vasodilatory and antiproliferative, and
hence targeting the vasculature rather than the right ventricle in
pulmonary hypertension.
Parameters of right ventricular function such as cardiac index
and mean right atrial pressure are the most important determi-
nants of survival in pulmonary arterial hypertension [1]. Multiple
signal transduction pathways are known to be involved in the
remodeling of the heart [6]. Although it is a matter of debate
which mechanisms are important for transition to failure and
hypertrophy, failure of the left ventricle are characterized to
varying degrees by changes in extracellular matrix composition,
energy metabolism, contraction, adrenergic signaling, and calcium
handling [7]. In the right ventricle from chronic hypoxic rats gene
expression studies have suggested a switch of metabolic genes
suggesting that the hypertrophic right ventricle changes from fatty
acid to glucose oxidation [8], and a recent microarray study of the
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hypertension suggested that pro-apoptotic pathways and intracel-
lular calcium handling enzymes play a role for development of
failure [9–11] while growth genes such as mitogen activated
protein kinase (MAPK) are pivotal in compensated hypertrophy
[9]. However, in contrast to the thick-walled left ventricle, the
right ventricle has a concave thin wall opposite to the convex
interventricular septum, and the anatomic response to pressure
overload of the right ventricle is different from the left ventricle
[1], hence suggesting that other signaling pathways may play a role
for development of right ventricular hypertrophy in response to
pressure load.
Global gene analysis has been employed to map the expression
profile of cardiac hypertrophy in man [12] and in the lungs and
peripheral blood cells from patients with severe pulmonary arterial
hypertension [13,14] as well as in lungs of mice with hypoxic
pulmonary hypertension [15]. These types of global gene analyses
are believed to be of significant value both for understanding and
predicting disease processes also in pulmonary hypertension [16].
The present study investigated the changes in global gene
expression by gene chip analysis during the development of right
ventricular hypertrophy induced by chronic hypoxic pulmonary
hypertension in rats. Most of the regulated genes in the hypoxic
model were expected to be associated to the adaptive response to
sustain right ventricular output, but some may be exclusively
associated to hypoxia. Therefore, gene expression changes were
also analyzed in rats undergoing pulmonary trunk banding (PTB),
another animal model for pressure loading of the right ventricle.
The alterations in expression of a subset of genes were confirmed
by quantitative realtime polymerase chain reaction (qPCR),
immunoblotting, and immunohistochemistry.
Methods
Ethics Statement
All animal procedures followed the revised NIH publication
no. 86–23, entitled: ‘‘Principle of laboratory animal care’’, and
were performed according to the Danish legislation with
permission (no. 2006/561–1160) from the Animal Surveillance
Committee, The Danish Ministery of Justice.
Animal models of right ventricular hypertrophy
48 male Wistar rats (10 weeks, weight approximately 290 grams)
were divided into two groups of 24 animals. Each group was
divided into subgroups of six animals. Four subgroups were
maintained at hypobaric, hypoxic pressure. Four subgroups were
maintained at normobaric, normoxic pressure and served as
controls (Table 1). The hypoxic group was placed in a hypobaric
chamber, where the ambient pressure was continuously held at
500 mbar which was equivalent to rats breathing 10% oxygen at
standard pressure. The temperature in the chamber was
maintained at 21–22uC and the chamber was ventilated with air
at approximately 45 l min
21 through an inlet valve with the aid of
a vacuum pump. The four subgroups were maintained in these
hypoxic, hypobaric conditions for 1, 2, 3 or 4 weeks and studied
immediately after removal from the chamber. The hypoxic
chamber was opened once a week for approximately 30–40
minutes for cleaning and supplying purposes. Age-matched
controls were maintained in similar but normoxic, normobaric
chambers. All animals were provided with chow and water ad
libitum.
For the PTB experiment, 46 male Wistar rats were divided into
two groups. One group underwent PTB operation, and the other
group underwent sham operation. Sham operated animals
underwent the same procedure as PTB rats except for banding
of the pulmonary trunk. Animals were subdivided into 4 groups
and examined 2, 3, 5 and 6 weeks after the operation. 4 Sham and
4 PTB animals were randomly selected for gene chip analysis
(Table 1). The animal model for pressure loading of the right
ventricle using PTB has been described in detail in a previous
publication [17].
In the experiment with chronic hypoxic rats, body weight (BW)
and systemic systolic blood pressure (SSBP) of the animals were
measured on the day of sacrifice. SSBP was measured using the
tail cuff method with a plethysmograph (Digital Pressure Meter LE
5000 with tail cuff). Before measurements, rats were preheated for
20 minutes at 35uC in their cages. Rats were then placed in a
heated Plexiglas tube (35uC). In each rat, three subsequent
measurements within a difference of 5 mmHg were made, and the
mean values were used. For measurement of right ventricular
systolic pressure (RVSBP), rats were fully anaesthetized with an
intraperitoneal injection of Midazolam 0.825 ml/kg, Fentanyl
0.825 ml/kg and sterilized water 0.825 ml/kg. For maintenance,
intraperitoneal injection of 100 mL Fentanyl was given every 30
minutes. The external jugular vein was isolated by blunt dissection
and ligated (using SeralonH 3/0 – Serag Wiessner). A small hole
was cut in the vein and through this a catheter (30 cm. Tygon
micropore, OD: 0.76 mm, ID: 0.25 mm, Norton performance
plastics, OH, USA) slightly bended in one end, was inserted and
led into the right ventricle through the right atrium (marks on the
catheter at four to five cm indicates this location). The pressure
profile was simultaneously registered via a pressure transducer
(MLT0699 Disposable BP Transducer, ADInstruments, CO,
USA), an amplifier (ML118G Quad Bridge Amp, ADInstruments)
and through a signal box (PowerLab 4/20, ADInstruments)
registered on a computer (software: Chart v5.0, ADInstruments).
Once the catheter was in place, the pressure was left to stabilize
over a period of approximately 5 to 10 minutes. The rats were
Table 1. Experimental design.
Animal groups Week 1 Week 2 Week 3 Week 4 Total GeneChip
Intervention (hypoxia) 6 6 6 6 24 16*
Control (normoxia) 6 6 6 6 24 12*
Week 2 Week 3 Week 5 Week 6 Total GeneChip
Intervention (PTB) 5 6 6 6 23 4*
Control (Sham) 5 6 6 6 23 4*
*Three animals from each control and four animals from each hypoxic subgroup were used for GeneChip analysis. Four animals from each group either pulmonary trunk
banded (PTB) or sham at week 5 were used for GeneChip analysis.
doi:10.1371/journal.pone.0015859.t001
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mortem by centrifuging the blood (Micro-Hematocrit Centrifuge,
model MB, 11,700 RPM, 13,700 6 g, International Equipment
Company, MA, USA) for 10 minutes.
In the PTB experiment, invasive pressure measurements were
performed as previously described [17].
Assessment of right ventricular hypertrophy
Immediately after the rat was decapitated, the heart was
removed and placed in diethylpyrocarbonate (DEPC) treated
water. For gene expression analysis a piece offour times four mm
of the free wall of the right ventricle was cut out, and placed in
RNAlater (Ambion Inc., TX, U.S.A.). The atria of the heart were
removed and the right ventricle separated from the left ventricle
and septum. Right ventricle (including the piece cut out for gene
expression analysis) and left ventricle was weighed separately.
Right ventricular weight to body weight ratio (RV/BW) and the
entire heart weight to body weight (HW/BW) were calculated.
Morphometric measurements
Tissue from the right ventricle was stained with reticulin that is
useful to outline the architecture. The myocardial cell was
considered to represent a near cylinder with a nucleus placed in
the centre of the cell. Measurements were restricted to the nuclear
areas. The smallest diameter was chosen as the one representing
the actual diameter. The measurements were done on as many
cells as possible in a field of vision. Only cells represented by a
nucleus were measured. The fields of vision were randomly picked.
Gene chip analysis
The gene expression profiles was obtained by the use of
Affymetrix GeneChips (GeneChipH Rat Genome 230 2.0 Array,
Affymetrix Inc., CA, U.S.A.). Protocols for the analysis of
Affymetrix GeneChips and the evaluation of the sensitivity and
quantitative aspects of the method have been previously described
[18]. The raw data files are available in European Molecular
Biology Laboratory, European Bioinformatic Institute, Microarray
Informatics, (http://www.ebi.ac.uk/miamexpress). 293 genes
were chosen for analysis in the hypoxic and PTB experiment
(see details in the statistical analysis section).
qPCR analysis
In the present project we used an Applied Biosystems 7000
Real-Time PCR System (Applied Biosystems, CA, U.S.A.) and
probes composed of LNA
TM molecules (Exiqon, Denmark). LNA
(Locked Nucleic Acid) is a bicyclic nucleic acid where a
ribonucleoside is linked between the 29-oxygen and the 49-carbon
atoms with a methylene unit (CH2). As with the DNA probes each
of the 90 LNA probes in the ProbeLibrary
TM kit is labeled with
fluorescein (reporter) and a non-fluorescent quencher.
Primers (forward and reverse) and probes used were: adrenergic
receptor, alpha 1B (a1B-AR): 59-cgtatccttgggtgccagt-39,5 9-cacg-
gccggtaggtgtaa-39, probe #22; aquaporin 7: 59-tccccggttcttc-
actttc-39,5 9-acccaccaccagttgttcc-39, probe #15; triadin 1: 59-gtg-
gactacaaaaacttttcagca-39,5 9-cagcatcgttcactagttttagagg-39, probe
#20; CD151 antigen: 59-acggaacctgttacgcttgt-39,5 9-cagca-at-
gatctccagaagga-39, probe #5; tissue transglutaminase (tTG): 59-
agctggagagcaacaagagc-39,5 9-gcctggtcatccaggactc-39, probe #9;
transforming growth factor, beta 1 (TGF-b1): 59-cctgcc-cctac-
atttgga-39,5 9-tggttgtagagggcaaggac-39, probe #73; Ubiquitin C:
59-caggacaaggagggcatc-39,5 9-gccatcttccagctgctt-39, probe #90;
myosin regulatory light chain: 59-cttcgcttgcttcgatgag-39,59-gtgag-
cagctccctcaggt-39 , probe #31; clathrin, light polypeptide (Lcb):
59-tggagagaggagc-agaagaaa-39,5 9-cactcctgttcggtcacctt-39, probe
#89; Similar to C11orf17 protein: 59-ctcagactc-ggggcacag-39,5 9-
atgcttcctggaccaacaga-39, probe #40.
Immunoblotting
Frozen samples of the right ventricle from chronic hypoxic and
normoxic rats were homogenized, extracted in 300 ml lysis buffer
(20 mM Tris-HCl, 5 mM EGTA, 150 mM NaCl, 20 mM
glycerolphosphate, 10 mM NaF, 1% Triton X-100, 0.1%
tween-20, 0.02 mM ortho-vanadate, 40 nM PMSF, PIM) and
centrifuged at 3000 rpm at 4uC for 15 minutes. The supernatant
was removed and protein concentration was measured by double
determination of the samples against a standard curve with
known concentration of albumin using Bio-Rad Protein Assay
(Bio-Rad Laboratories, CA, USA). Protein lysate was mixed with
sample buffer (350 mM Tris-HCl, 10% dithiothreitolsodium-
laurylsulfate, 30% glycerol, 0.123% bromphenol blue). Samples,
containing equal amounts of protein, and Protein Stain marker
(Bio-Rad Laboratories) were loaded to the gel (Criterion XT Bis-
Tris gel 4–12%, Bio-Rad Laboratories) and separation was
carried out in the Criterion Electrophoresis System (Bio-Rad
Laboratories) using XT-MOPS as a running buffer. The proteins
were transferred from the gel to a polyvinylidine difluoride
membrane for 1 hour at 100 V. The membrane was blocked in
5% milk for 2 hours at 20uC and afterwards incubated with
primary antibody diluted in 5% milk over night at 4uC. The
membrane was washed four times in TBS-T (stock: 10 mM tris/
base, 2M NaCl, 1 mM EDTA 0.1% tween-20–200 ml stock,
1800 ml MQ-water, pH adjusted to 7.5) and then incubated in
secondary antibody for 2 hours at 20uC. Then again washed four
times in TBS-T and finally the blots were detected by enhanced
chemiluminiscence system (ECL Plus Western Blotting Detection
System, GE Healthcare UK Ltd., UK). Differences in protein
abundance were determined by densitometry (Image Quant TL;
Amersham Biosciences, UK). The known amount of loaded
protein was used as loading control.
Table 2. Parameters describing the pulmonary and systemic
impact of hypoxia.
Week 1 Week 2 Week 3 Week 4
Hematocrit (%)
Normoxia 38.760.9 39.062.6 39.061.5 39.061.4
Hypoxia 50.261.3* 54.361.7* 51.561.9* 51.861.5*
SSBP (mmHg)
Normoxia 131.362.2 127.862.4 124.764.9 124.762.3
Hypoxia 128.762.8 124.362.8 129.562.5 122.263.6
Body weight (gram)
Normoxia 331612 342611 334612 364610
Hypoxia 298611 300611 342610 310619*
HW/BW (%)
Normoxia 0.2760.005 0.2660.009 0.2560.009 0.2460.007
Hypoxia 0.2960.004 0.3160.008* 0.3360.014* 0.3260.010*
SSBP: Systemic systolic blood pressure; HW/BW: Heart weight to body weight
ratio.
n=6 in both groups at all time points. Values are means 6 SE. *P,0.05 vs.
normoxia at same time point.
doi:10.1371/journal.pone.0015859.t002
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Primary antibodies used were: anti-acetyl-Coenzyme A acyl-
transferase 2 (ACAA2) (cat.nr. 11111-1-AP, Ptg.Lab, IL, USA),
anti-hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coen-
zyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional
protein), alpha subunit (HADHA) (cat.nr. 10758-1-AP, Ptg.Lab,
IL, USA), anti-aquaporin 7 (cat.nr. AB3076, Chemicon Interna-
tional, MA, USA), anti-monoamine oxidase A (MAOA) (cat.nr.
10359-1-AP, Ptg.Lab, IL, USA), anti-tissue transglutaminase
(tTG) (TGase II Ab-2 (TG-100), Thermo Scientific, CA, USA),
anti-endothelin receptor B (ETB) (cat.nr. ab1921, Abcam, UK).
Secondary antibodies used were: horse radish peroxidase (HRP)
conjugated goat anti-rabbit IgG (Santa-Cruz biotechnology, CA,
USA), HRP conjugated goat anti-mouse IgG (Zymed, CA, USA),
HRP conjugated rabbit anti-chicken (ab6753, Abcam).
Immunohistochemistry
Pieces from the right ventricle from normoxic and hypoxic rats
were stored in formalin 4% until they were embedded into
paraffin. Slices of approximately 3 mm were made from each
piece. Removing paraffin from the slices was done by washing in
different solutions each for 5 minutes following the schedule: 2 x
xylene (Xylene – mixture of isomers (AppliChem, Germany)),
2699% ethanol, 96% ethanol, 50% ethanol and water. The slices
were incubated in 3% H2O2 for 10 minutes and afterwards
washed 265 minutes in Coon’s buffer (Na2H2PO4 (2H2O),
NaH2PO4 (H2O), NaCl – ad. 10,000 ml H2O). Slices were then
pretreated with either citrat buffer (10 mM (Tri-sodiumcitrate
dihydrat 5 mM, dinatriumhydrogencitrat 5 mM, pH adjusted to
6.0)) or TEG buffer (Tris 10 mM, EGTA 0.5 mM, pH adjusted to
9.0) for 265 minutes in microwave at 650 W and afterwards
washed in Coon’s buffer. 10% bovine serum in solution of 1%
bovine serum albumin dissolved in Coon’s Buffer (BSA1%) was
added to avoid unspecific binding of the antibodies. The serum
was removed and the primary antibody, the same as used for
immunoblotting, diluted in BSA1% was added and incubating
over night at 4uC in a moisture chamber.
The slices were washed in Coon’s buffer and then incubating
with secondary antibody (Bionylated Link - Universal LSAB
TM2
Kit/HRP, Rabbit/Mouse, Dako, CA, USA) for 20 minutes at
20uC in a moisture chamber. Again washing with Coon’s buffer
and incubation with streptavidin (Streptavidin, Dako) for 20
minutes at 20uC in a moisture chamber. After washing with
Coon’s buffer DAB (DAB Chromogen (tablets dissolved in
Coon’s buffer), Dako) was added and incubating for 5 minutes.
Slices were incubated with Mayer’s hematoxylin for 1 minute,
washed in H2O and incubating for 5 minutes in each solution:
50% ethanol, 96% ethanol and 99% ethanol. Negative controls
were made exactly indentical but without incubation with
primary antibody.
Statistical analysis
The data obtained in the hypoxic experiment was firstly filtered
to include probe sets with at least one present call in all 28 chips
and secondly logarithmic transformed. A t-test for difference
between the hypoxic and the normoxic groups, that adds the
effects from the four time points (allowing for different general
levels at the four time points) was calculated. The corresponding P-
value from the appropiate t-distribution was calculated for each
gene.
The calculated P-values were used to rank the genes within each
test. To estimate how many of the called genes that were falsely
positively called, we estimated a false discovery rate (FDR),
avoiding the assumptions of the data being independent and
normally distributed. The FDR was calculated by comparing the
original data to a reference distribution based on permutated data.
Permutation consists in permutating group labels while keeping
the size of the two groups. In this experiment we generated
alternative arrangements by exchanging two individuals between
the control and the intervention group for each of the four time
points. For the whole experiment, there were a total of 104.976
different permutations. 500 randomly picked permutations were
chosen, and for each of the 500 permutated experiments a tsum
perm. test was calculated, and the corresponding P-values were
found. FDR was found by calculating the ratio between the
median number of genes based on the permutated datasets with
P,0.0001 and the number of genes based on the original dataset
with P,0.0001.
In the PTB experiment, the genes that were found to be
significantly differentially expressed in the hypoxic experiment,
Figure 1. Right ventricular systolic blood pressure (RVSBP) and
right ventricular hypertrophy in hypoxic experiment. A: changes
in RVSBP in the normoxic and hypoxic groups at the four time points.
RVSBP was constant in the normoxic group and significantly increased
in the hypoxic groups after 2 weeks. B: temporal change in right
ventricular hypertrophy in the hypoxic experiment assessed by right
ventricular weight relative to body weight ratio (RV/BW) shows
significant increase due to hypoxia. n=6 in both groups at all time
points. Values are means 6 SE. *P,0.05 vs. normoxia at same time
point.
doi:10.1371/journal.pone.0015859.g001
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experiment, and differences between the two groups were analysed
using Student’s t test.
Results from immunoblotting, qPCR, morphometric and
hemodynamic measurements from both the PTB and hypoxic
experiment were analyzed separately by using two-way analysis of
variance (ANOVA) comparing hypoxia or PTB to time. In case of
significance a Bonferroni post hoc test was made. Statistical
calculations were made by using GraphPad Prism version 4.03
(GraphPad Software Inc, San Diego, CA, USA).
All over, P-values of less than 0.05 were considered significant.
Results
Functional Data
Hematocrit, SSBP, BW and HW/BW are listed in Table 2. The
hematocrit was 39% in the normoxic group. Hypoxia increased
the hematocrit to 50–54%. SSBP was unaltered by hypoxia. The
normoxic animals gained weight during the four weeks, while the
hypoxic rats had a significant lower body weight after four weeks
of experiment. HW/BW in the hypoxic group showed a significant
increase at week two, three and four.
RVSBP was constant in the normoxic group (18–25 mmHg)
but raised by hypoxia from 32 mmHg at week one to 40–
Figure 2. Morphometric measurements of the right ventricle. A:
cardiomyocyte diameter was significantly increased by hypoxia
compared to normoxic controls. B: examples of staining with reticulin
in right ventricle samples from normoxic and hypoxic rats. n=5–6 in
both groups at all time points. Values are means 6 SE. *P,0.05 vs.
normoxia at same time point.
doi:10.1371/journal.pone.0015859.g002
Figure 3. RVSBP and RV/BW in the pulmonary trunk banding
(PTB) experiment. A: RVSBP was significantly increased due to PTB
compared to sham operated animals. B: temporal change in right
ventricular hypertrophy in the PTB experiment assessed by RV/BW and
compared to the sham group shows a significant increasing effect of
PTB. n=4–7 in both groups at all time points. Values are means 6 SE.
*P,0.05 vs. sham at same time point.
doi:10.1371/journal.pone.0015859.g003
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Public ID Encoded protein Fold changes
a
NM_012612 natriuretic peptide precursor type A +50.13
NM_019296 cell division cycle 2 homolog A (S. pombe) +6.21
NM_031131 transforming growth factor, beta 2 +5.60
NM_012843 Epithelial membrane protein 1 +5.25
AI145313 thymus cell antigen 1, theta +4.64
AB026903 decay-accelerating factor +2.31
D00688 monoamine oxidase A +3.44
BI298356 four and a half LIM domains 1 +3.07
M14400 creatine kinase, brain +2.95
AF413212 guanine nucleotide binding protein, alpha o +2.91
NM_019212 actin alpha 1 +2.85
NM_012886 tissue inhibitor of metalloproteinase 3 +2.72
NM_031545 natriuretic peptide precursor type B +2.68
L09752 cyclin D2 +2.52
AA851939 FXYD domain-containing ion transport regulator 6 +2.50
U54791 Chemokine receptor (LCR1) +2.47
AA945643 Chitinase 3-like 1 (cartilage glycoprotein-39) +2.38
AF095585 enigma (LIM domain protein) +2.38
Z78279 collagen, type 1, alpha 1 +2.37
AI227742 Bcl-2-related ovarian killer protein +2.29
NM_019237 procollagen C-proteinase enhancer protein +2.25
BM389019 fibrillin-1 +2.23
X57764 endothelin receptor B +2.23
AW143798 cyclin D1 +2.21
AF072892 chondroitin sulphate proteoglycan 2 (versican) +2.16
NM_019341 Regulator of G-protein signaling 5 +2.16
NM_134452 collagen, type V, alpha 1 +2.11
AB026665 peptide/histidine transporter PHT2 +2.11
NM_019386 tissue transglutaminase +2.08
AW253722 RAB13 +2.01
AI009597 FXYD domain-containing ion transport regulator 3 28.67
NM_031543 cytochrome P450, subfamily 2E, polypeptide 1 25.60
AF385402 Potassium channel, subfamily K, member 2 24.15
AI535411 myosin heavy chain, polypeptide 7 23.63
AJ243304 triadin 1 23.04
NM_019157 Aquaporin 7 22.82
BE103537 tropomyosin 1, alpha 22.81
U31554 limbic system-associated membrane protein 22.76
AI137995 sodium channel, voltage-gated, type IV, beta 22.50
NM_012505 ATPase, Na+K+ transporting, alpha 2 22.37
NM_080399 Smhs1 protein 22.18
NM_057197 2,4-dienoyl CoA reductase 1, mitochondrial 22.14
NM_030865 Myocilin 22.14
AF322216 immunoglobulin superfamily, member 1 22.14
NM_017079 CD1d1 antigen 22.13
NM_012793 guanidinoacetate methyltransferase 22.08
AA899304 acetyl-coenzyme A acetyltransferase 1 22.05
AW528891 potassium voltage gated channel, Shal-related family, m… 22.03
NM_016991 adrenergic receptor, alpha 1B 22.03
aValues are the average of a four-way analysis as described in Methods. Only genes with fold changes larger than 2 are included in this table.
doi:10.1371/journal.pone.0015859.t003
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almost unaltered in the normoxic group, while in the hypoxic
group RV/BW was increasing during the four weeks (Figure 1B).
There was a strong positive correlation between RVSBP and RV/
BW in the hypoxic experiment (n=48, R
2=0.66, P,0.0001).
The diameter of the cardiomyocytes increased significantly (31
to 64%) in the hypoxic group but within each group there was no
significant difference between the four different time points
(Figure 2A). Staining with reticulin did not reveal any other
differences between hypoxic and normoxic rats (Figure 2B).
In the PTB experiment, RVSBP was approximately constant in
the sham group (26 to 38 mmHg). RVSBP was significantly raised
in the PTB group at all time points (76 to 118 mmHg) (Figure 3A).
Temporal change in right ventricular hypertrophy was assessed by
RV/BW ratio. The degree of right ventricular hypertrophy in the
PTB group was increased significantly at all time points compared
to the sham group (Figure 3B). There was a strong correlation
between RVSBP and RV/BW (n=46, R
2=0.76, P,0.0001).
Gene expression data
Table 3 contains results for 49 genes from gene chip analysis for
genes up- or down-regulated with a fold change greater than two.
The validation of the gene expression profiles was done by
qPCR. We chose four upregulated (CD 151 antigen, tTG, TGF-
b1 and Similar to C11orf17 protein), three downregulated (a1B-
AR, aquaporin 7, and triadin 1) and two genes without change
(myosin regulatory light chain and clathrin – light polypeptide).
Ubiquitin C was used for normalization. The qPCR results were
in accordance with the gene chip data (Figure 4A,B), exemplified
by aquaporin 7 and tTG. The correlation between the gene chip
and qPCR results was tested by comparing 3 up-regulated, 4
down-regulated and 2 genes with no change in expression
according to the gene chip tsum analysis. There is a strong
positive correlation between gene chip detection (normalized to 0)
values and the qPCR detection values (normalized to 0) and in the
hypoxic experiment (n=72, R
2=0.70) (Figure 5).
The signal log ratio estimates the magnitude and direction of
change of a transcript when two arrays are compared (experiment
versus control). Signal log ratios from the hypoxic and the PTB
experiments were plotted for 288 genes (5 genes were excluded of
the original 293 genes tested because they showed absent calls in
the PTB experiment). 266 were regulated in the same direction or
were unchanged in the two experiments (Wilcoxon signed rank
test: P,2.2610
216). Of these genes, 172 were non-expressed
sequence tags (non-EST) involved in apoptosis, inflammation,
heart function, and growth and the remaining 94 were EST. Of
the 22 genes regulated differently, 11 were up-regulated and 5
unaltered in the PTB experiment but down-regulated in the
hypoxic experiment, 3 were down-regulated in PTB and up-
regulated in hypoxia and 3 were EST (Table 4). There is a strong
positive correlation between the log ratios of gene expression in the
hypoxic and the PTB experiment (R
2=0.69, P,0.05, n=288)
(Figure 6). Limiting the analysis to genes where the fold change is
larger than 2 yielded an even stronger correlation (R
2=0.84,
P,0.05, n=125) of gene expression in the hypoxic and PTB
experiment.
Figure 4. qPCR analysis of aquaporin7 and tissue transgluta-
minase. A: gene expression of the aquaporin 7 mRNA by use of gene
chip and qPCR shows a decrease in gene expression according to
hypoxia. B: gene expression of tissue transglutaminase mRNA by use of
gene chip and qPCR shows the opposite impact of hypoxia by
increasing gene expression. n=6 in both groups at all time points.
doi:10.1371/journal.pone.0015859.g004
Figure 5. Correlation of the gene chip and qPCR gene
expression results. The correlation is tested by comparing three
upregulated, four downregulated and two not regulated genes
(according to the gene chip, tsum analysis). There was found significant
correlation between qPCR and gene chip analysis. Values are means 6
SE. *P,0.05 vs. normoxia, gene chip at same time point, {P,0.05 vs.
normoxia, qPCR at same time point.
doi:10.1371/journal.pone.0015859.g005
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pulmonary trunk banded (PTB) compared to sham-operated rats. There was found a positive correlation between regulation of the genes in
the two experiments with a significant correlation coefficient R
2=0.69 (P,0.05, n=288).
doi:10.1371/journal.pone.0015859.g006
Table 4. Differentially regulated genes in the right ventricle of pulmonary trunk banded (PTB) rats versus chronic hypoxic rats.
Public ID Encoded protein Fold change
PTB Hypoxia
NM_024400 A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS-1) 0.60 20.61
BG671506 avian sarcoma virus CT10 (v-crk) oncogene homolog 0.38 20.41
AI454911 endothelial monocyte activating polypeptide 2 0.15 20.28
BF282186 eukaryotic initiation factor 5 (eIF-5) 0.35 20.35
AI713966 insulin-like growth factor binding protein 3 0.41 20.84
NM_012588 insulin-like growth factor binding protein 3 0.33 20.78
NM_053713 Kruppel-like factor 4 (gut) 0.48 20.68
AA818911 mob protein 0.21 20.39
AI409862 protein phosphatase 1, catalytic subunit, beta isoform 0.22 20.37
NM_033096 protein phosphatase 1B, magnesium dependent, beta isoform 0.12 20.36
AY043246 regulator of G-protein signaling protein 2 0.44 20.99
AI454052 c-kit receptor tyrosine kinase 20.24 0.91
AW914928 DEAD (aspartate-glutamate-alanine-aspartate) box polypeptide 25 20.36 0.51
BI275583 lectin, galactoside-binding, soluble, 2 (galectin 2) 20.17 0.15
In addition 4 genes (LYRIC, glioma tumor suppressor candidate region gene 2, splicing factor (arginine/serine-rich 5), transducer of ERBB2 1, and TRAP-complex gamma
subunit) were unaltered in PTB, but down-regulated in hypoxia, but with fold changes less than 0.5.
doi:10.1371/journal.pone.0015859.t004
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Figure 7 shows the representative immunoblots. Six proteins
were chosen for immunoblotting based on the gene chip that
showed three genes were downregulated (ACAA2, HADHA and
aquaporin 7) and three were upregulated (tTG, MAOA and ETB).
By use of antibodies against these proteins we showed that some of
the changes found on gene levels are also reflected at protein level.
ACAA2, HADHA and aquaporin 7 were not significantly
downregulated, but the tendency is clear (Figure 8A–C). MAOA
and tTG were significantly upregulated in hypoxic rats after 2, 3
or 4 weeks when compared to normoxic controls (Figure 8D–E).
Finally, ETB was only significantly upregulated after 3 weeks of
hypoxia (Figure 8F).
Immunohistochemistry
By incubating slides from the right ventricle from hypoxic and
normoxic rats with antibodies used for immunoblotting we were
able to evaluate the localization of the proteins. Controls were
made without primary antibody incubation (Figure 9A). For the
proteins participating in beta-oxidation, ACAA2 and HADHA,
the localization is intracellular in the cardiomyocyte (Figure 9B–
C). Aquaporin 7 was also located in the cardiomyocyte at the
cellular membrane (Figure 9D). MAOA was also upregulated on
the immunostainings when compared to normoxic controls and
the location is intracellular (Figure 9E). Finally, tTG was also
located to the cardiomyocyte mainly in the cytosol (Figure 9F).
Discussion
The main findings of the present study are addressing gene
expression common for the pressure loading of the right ventricle
in both chronic hypoxic rats and rats with banding of the
pulmonary trunk. The present study revealed alterations in
expression of 172 genes involved in apoptosis, inflammation,
heart function, and growth. A small subset of differentiated genes
in the hypoxia and PTB groups suggests pressure load as the main
contributer to development of right ventricular hypertrophy.
GeneChip analysis of the right ventricle was confirmed by qPCR
for a subgroup of genes and was further substantiated by
measuring protein expression showing a marked upregulation of
tTG due to right ventricular hypertrophy.
Role of hypoxia versus pressure load in right ventricular
hypertrophy in pulmonary hypertension
The hypobaric hypoxia model has been used in several studies
for induction of pulmonary hypertension in rats and has shown
increase of RVSBP and right ventricular weight [19]. Another
approach to induce high RVSBP and to increase right ventricular
weight is by PTB [17,20]. By comparing these two animal models,
it is possible to distinguish the isolated effect of respectively
pressure load and hypoxia. There was a significant correlation of
genes changed in the right ventricle of chronic hypoxic rats with
the changes observed in the PTB experiment and this correlation
was even stronger when only genes regulated more than two-fold
were considered. These findings suggest that pressure load is the
main factor altering gene expression in the right ventricle in rats
with pulmonary hypertension induced by hypoxia.
Comparing chronic hypoxia and PTB identified a small
subgroup of genes changing in opposite directions suggesting that
hypoxia alone has an impact on the gene expression in the right
ventricle. Thus, c-kit receptor tyrosine kinase and DEAD
(asparatate-glutamate-alanine-asparatate) box polypeptide 25 were
upregulated in hypoxia and downregulated in the PTB experi-
ments, while insulin-like growth factor binding protein 3 and
Figure 7. Representative immunoblots for proteins measured in the right ventricle from normoxic and hypoxic rats. ACAA2: acetyl-
Coenzyme A acyltransferase 2, HADHA: hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), alpha subunit.
doi:10.1371/journal.pone.0015859.g007
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c-kit receptor tyrosine kinase and insulin-like growth factor
binding protein 3 have previously been described to be involved
in hypoxia-induced angiogenesis [21,22], and insulin growth
factor 1 stimulation in mouse fibroblasts resulted in upregulation
of DEAD [23]. Therefore, hypoxia seems to directly affect gene
expression in the right ventricle. However, in all cases the fold
changes in gene expression comparing the PTB and hypoxic
Figure 8. Immunoblottings of right ventricle samples from normoxic and hypoxic rats. Proteins participating in metabolism A: ACAA2, B:
HADHA and C: aquaporin 7 show tendency to downregulation by hypoxia. D: monoamine oxidase A, E: tissue transglutaminase and F: endothelin
receptor B were all upregulated by hypoxia. ACAA2: acetyl-Coenzyme A acyltransferase 2, HADHA: hydroxyacyl-Coenzyme A dehydrogenase/3-
ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit. Values are means 6 SE and are calculated as
percent of normoxia 1 week. n=6 in both groups at all time points. *P,0.05 vs. normoxia at same time point.
doi:10.1371/journal.pone.0015859.g008
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(Table 4), and it cannot be excluded that differences in pressure
load comparing chronic hypoxic rats and PTB rats may also
contribute to the differential gene regulation.
Previous studies have also provided evidence suggesting that
mechanical load of the right ventricle from rats with pulmonary
hypertension influences gene expression [11]. Thus, atrial
natriuretic peptide expression, probably induced by stretch of
the myocardium, was upregulated in the right ventricle from rats
with pulmonary hypertension induced by either moncrotaline or
hypoxia [8,9], and in agreement with these findings, both
natriuretic peptide precursor type A and B were markedly
increased in the present study. Genes involved in cell proliferation,
the cyclin family of genes and BCl2, were upregulated in the right
ventricle of rats with pulmonary hypertension induced by
monocrotaline [9,10], and the same was the case for cyclin D1
and D2 as well as BCl2 in the present study. In addition, several
signaling processes involving fetal gene re-expression, activation of
protein translocation, increase in mass, and enlargement of cell
size/volume have been identified as markers of hypertrophy as a
response to hemodynamic overload [24]. In the present study the
diameter of the cardiomyocytes was increased, and alpha-actin
expression was upregulated together with four and a half LIM
domains 1 (FHL), and enigma (LIM domain protein). FHL is
contained in a complex within the cardiomyocyte sacromere and
mice lacking FHL displayed a blunted hypertrophic response
suggesting FHL1 to mediates hypertrophic biomechanical stress
responses in the myocardium [25], while the Enigma protein
family are Z-line proteins at the border between two sarcomers
[26]. Thus, upregulation of a series of genes in the present study
also suggest that mechanical load regulate gene expression and
results in right ventricular hypertrophy.
Role of specific signal pathways changed in right
ventricular hypertrophy
During development of right ventricular hypertrophy the
myocardium changes metabolism to avoid ischemia [27].
Normally the major substrate for heart metabolism is free fatty
acids that account for 60–80%. The remaining part comes from
metabolism of carbohydrates, but during development of left
ventricular hypertrophy and heart failure the ratio alters towards
increased carbohydrates as cardiac fuel substrate and augmented
mitochondrial respiratory capacity which is considered to play a
central role in hypoxia-mediated cardioprotection [27]. A study of
gene expression from chronic hypoxic rats showed increased
expression of genes associated to glucose metabolism and they also
found changes in the left ventricle, which indicates that not only
myocardial hypertrophy causes changes, but also chronic hypoxia
contributes to altered gene expression [8]. Indeed, in the present
study genes encoding for enzymes participating in beta-oxidation
of fatty acids (ACAA2 and HADHA) were downregulated in right
ventricles from hypoxic rats. The tendency was reflected at protein
level, although not significantly and supports that pressure load by
itself is able to cause a shift in genes related to myocardial
metabolism from free fatty acids to carbohydrates.
Aquaporin 7 is a water and glycerol channel that has been
found especially in adipocytes and skeletal muscle cells in the
human body. The overall function of aquaporins is to maintain
cellular water homeostasis [28,29]. Studies of aquaporin 7 showed
that it is expressed in cardiac tissue from mice, rats and humans
[30]. Our results confirmed these findings both by gene chip,
qPCR and immunoblotting. Moreover, we found that hypoxia
decreases gene expression for aquaporin 7, although this was not
confirmed at protein level. Skowronski et al. found that aquaporin
7 is only localized in small vessels in cardiac tissue, and these
observations agree with our findings [31]. A downregulation of
aquaporin 7 in hypoxic rats may reflect reduced glycerol transport
as a consequence of a shift of the metabolism from fatty acids to
carbohydrates.
Hypertrophy of the ventricle also leads to remodeling of the
ventricular wall and altered expression of structural proteins in the
myocardium and in the surrounding tissue. Studies of tTG in left
the ventricle show association between the expression of tTG and
development of ventricular hypertrophy [32,33]. The mechanism
is primarily through its action as TGase leading to structural
changes of actin and myosin, but also more or less through the
GTPase activity. tTG is coupled to the a1B-AR as Ga-protein
[34]. Overexpression of a1B-AR is known to induce cardiac
Figure 9. Immunostainings of slides from the right ventricle
from rats exposed to normoxia or hypoxia for 2 weeks. A:
Negative controls without incubation with the primary antibody. The
bar on control picture shows the size reference (50 mm) for all pictures.
B: ACAA2 C: HADHA, D: aquaporin 7, E: monoamine oxidase A, F: tissue
transglutaminase. All proteins were found to be located to the
cardiomyocyte and only aquaporin 7 was thought to be located to
the cellular membrane whereas the other proteins is located to the
cytosol.
doi:10.1371/journal.pone.0015859.g009
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shown that it is downregulated on mRNA level in vascular smooth
muscle cells from chronic hypoxic animals [36], and that knock-
out of the receptor did not alter development of right ventricular
hypertrophy and the increase in RVSBP [37]. The conclusion of
these studies is that a1B-AR is associated to vascular smooth
muscle cell proliferation. Our findings show that the a1B-AR is
downregulated in the right ventricle at mRNA level, while the
potential coupling protein tTG is markedly upregulated and
associated to right ventricular hypertrophy in rats with pulmonary
hypertension. The exact role of a1B-AR is still unknown but it
seems to play an adaptional role to avoid development of cardiac
hypertrophy according to pulmonary hypertension.
Transforming growth factor beta 1 (TGF-b1) is thought to be
associated with proliferation of cells during development of
hypertrophy and cell division. Studies of rats with pulmonary
hypertension and right ventricular hypertrophy induced by
monocrotaline showed by qPCR analysis increased levels of
TGF-b1 in the right ventricle but not in the left ventricle
indicating association to right ventricular hypertrophy [38]. Also
immunoblottings of pulmonary arteries from chronic hypoxic rats
showed association between TGF-b1 and increased proliferation
of vascular smooth muscle cells [39]. These findings indicate that
TGF-b1 is associated both to right ventricular hypertrophy and
vascular smooth muscle cell proliferation. Our studies support that
TGF-b1 appears to play a role in development of right ventricular
hypertrophy.
MAOA is an enzyme located to the mitochondria of the
cardiomyocytes and metabolizes epinephrine, norepinephrine,
and serotonin (5-HT). Studies have shown that 5-HT is associated
to ventricular hypertrophy by binding to its receptor 5-HT2B, and
that it induces oxidative stress and apoptosis [40]. It has been
found that blocking of the 5-HT2B receptor only partly inhibited
the effect of 5-HT, and that inhibition of MAOA prevented the
hypertrophic effect of 5-HT [41]. Overexpression of the 5-HT2B
receptor leads to left ventricular hypertrophy. The localization of
MAOA has been found to be intracellular [42,43]. Our findings
indicate an association between right ventricular hypertrophy and
the expression of MAOA. Moreover, we evaluated the localization
of MAOA and found that it is located to the cardiomyocytes and
probably to the mitochondria, which are highly expressed in
cardiomyocytes and is the place where catecholamines and 5-HT
are metabolized. Reactive oxygen species (ROS), a product from
oxidation of 5-HT catalyzed by MAOA, is related to right
ventricular hypertrophy and ROS has been found to be located to
the mitochondria [44]. This indicates that metabolization of 5-HT
and thereby MAOA is located here.
The effects of endothelin are mediated by two distinct receptors
termed ETA and ETB, where 90% of endothelin receptors belong
to the ETA subtype in cardiomyocytes, and their stimulation has a
positive inotropic effect [45]. Cardiac ETB receptors may
contribute to clearance of circulating endothelin and together
with the ETA to cardiac fibrosis and cardiomyocyte hypertrophy
[45,46]. In the present study only the ETB receptor expression was
elevated in the right ventricle as well as expression of several
collagens e.g. collagen type 1 alpha 1 and collagen type V alpha 1
(Table 3). The dual ETA/ETB receptor antagonist, bosentan
reduces right ventricular hypertrophy in pulmonary hypertension
in chronic hypoxic rats [47], but at present it is unclear whether
the block of endothelin clearance and pulmonary vascular dilation
by ETB receptors outweigh the beneficial effects of blocking both
the ETA and ETB receptors in pulmonary hypertension due to
hypoxia.
In conclusion, we have found that several genes are altered
during development of right ventricular hypertrophy induced by
pulmonary hypertension in chronic hypoxic rats. In case of the
metabolic genes the effect of high pressure on the right ventricle
appears compensated at the protein level, while both expression of
genes and proteins of importance for myocardial function and
remodelling are altered by the increased pressure load of the right
ventricle. These findings imply that treatment of pulmonary
hypertension, in addition to reduction of pulmonary vascular
resistance, should also aim at reducing right ventricular pressure or
by direct effects on the heart limit the organ damaging effects of
high pulmonary pressure.
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